A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone - Mamo, D; Kapur, S; Shammi, C M (Am J Psychiatry, 2004)
et al.